hydantoins has been researched along with Colonic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Božić, B; Matić, M; Nedeljković, BB; Obradović, A; Ognjanović, B; Ušćumlić, G; Vukić, M; Vuković, N; Đurđević, P | 1 |
| Arai, T; Awata, A; Fujino, H; Murayama, T; Okura, I; Oyama, S; Regan, JW; Yamazaki, R | 1 |
| Amaral, L; Handzlik, J; Kiec-Kononowicz, K; Molnar, J; Ocsovszki, I; Spengler, G; Viveiros, M | 1 |
3 other study(ies) available for hydantoins and Colonic Neoplasms
| Article | Year |
|---|---|
Anti-Tumor Mechanisms of Novel 3-(4-Substituted Benzyl)-5-Isopropil-5- Phenylhydantoin Derivatives in Human Colon Cancer Cell Line.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HCT116 Cells; Humans; Hydantoins; Molecular Structure; Structure-Activity Relationship; Tumor Cells, Cultured | 2019 |
A novel indole compound, AWT-489, inhibits prostaglandin D2-induced CD55 expression by acting on DP prostanoid receptors as an antagonist in LS174T human colon cancer cells.
Topics: Carcinogenesis; CD55 Antigens; Cell Line, Tumor; Colonic Neoplasms; Cyclic AMP; Dinoprostone; Drug Design; Gene Expression Regulation, Neoplastic; Humans; Hydantoins; Indoles; Prostaglandin D2; Receptors, Immunologic; Receptors, Prostaglandin; RNA, Messenger | 2014 |
Modulation of multidrug efflux pump activity by new hydantoin derivatives on colon adenocarcinoma cells without inducing apoptosis.
Topics: Adenocarcinoma; Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Humans; Hydantoins; Mice; Rhodamine 123 | 2011 |